not a clinician
the fullness rather than nausea description is the one
Spun off from a message in #cagrilintide on 2025-05-20. 17 messages, 3 participants.
- split_shipment — combination reading the fullness rather than nausea description is the one that matched my experience, for what that is worth 20:11
underwhelming for me, and i would rather log that than quietly stop and say nothing, held lightly, as always
different not less
told me something
did anyone add this to an existing tirzepatide dose rather than starting both, anyone at all
combination for me
update on the earlier thing the fullness thing is the part people describe differently, food stops being interesting rather than repellent, cold chain is the same as anything else
the effect built more slowly for me than i expected and i nearly gave up on it at week 4, an assay would be worth more than another anecdote
cagrisema thats it
[edited]is the fullness effect actually distinguishable from what the others do, even a rough answer helps
on the amylin is old point titration habits here are borrowed from the glp-1 channels, which is a habit rather than a finding, research use only, not approved for human use
combination is the interesting bit
sounds plausible, baseline and follow up
no difference i could see
that matched mine
underwhelming, logging it anyway monotherapy did work for me, just slower and smaller than i expected
this is research use material and the evidence base is younger than the compounds next door